The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder.
about
Cognitive dysfunction and work productivity in major depressive disorder.The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials.Sirukumab: A Potential Treatment for Mood Disorders?Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13).Treating to target in major depressive disorder: response to remission to functional recovery.How Studies of the Serotonin System in Macaque Models of Menopause Relate to Alzheimer's Disease1.Vortioxetine: A Review in Cognitive Dysfunction in Depression.Cost per successfully treated patient for vortioxetine versus duloxetine in adults with major depressive disorder: an analysis of the complete symptoms of depression and functional outcome.Insulin-like growth factor-1: a possible marker for emotional and cognitive disturbances, and treatment effectiveness in major depressive disorder.The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.Efficacy of vortioxetine in working patients with generalized anxiety disorder.Brain and behavioral correlates of insulin resistance in youth with depression and obesity.
P2860
Q30249792-16F85E32-3EC9-495E-9AAD-DBF181B1AD50Q37388486-07A9C924-A0EB-4020-A29C-A0A63DB45233Q37562443-B1A6754A-115C-4FA2-8896-30E4BFD5D0ABQ37741989-88741787-7574-4C9F-BCE9-493505F650C4Q38673546-55A6452A-5FAD-48FB-BCFD-59E1FB1C2A05Q38962789-C30ECC58-D264-44FD-BFF1-9725A9C8E95EQ38997216-FCF84E12-7EB4-45C5-AD4D-FABFDE7E42AEQ45937835-DC4F7C5B-5CEB-4E54-8E62-3B7677BDEDB3Q47098341-22266BF8-8D9C-417D-8D17-BD60FF630D9CQ47402907-17DB4100-1FAF-4310-BD20-E33990E522BAQ50224610-98ED48F5-CA75-4640-981F-07C068696039Q53422897-AF6EA288-92A9-4724-BF83-971FCD4B5EED
P2860
The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The prevalence, measurement, a ...... in major depressive disorder.
@en
type
label
The prevalence, measurement, a ...... in major depressive disorder.
@en
prefLabel
The prevalence, measurement, a ...... in major depressive disorder.
@en
P2093
P2860
P1433
P1476
The prevalence, measurement, a ...... in major depressive disorder.
@en
P2093
Andre F Carvalho
Danielle S Cha
Holly X Xiao
Kahlood Syeda
Nadia Maruschak
Rodrigo B Mansur
Roger S McIntyre
P2860
P2888
P304
P356
10.1007/S40263-015-0263-X
P50
P577
2015-08-20T00:00:00Z